Pfizer announced it is ending its development of its experimental oral GLP-1 drug to treat obesity, the company said on Monday, after a patient in a trial suffered a liver injury potentially caused by the experimental drug known as danuglipron.
Read More Pfizer Pulls Plug On Weight Loss Pill Amid Liver Damage FearsTag: CNBC
U.S. Stocks Rise As Global Trade Partners Seek Tariff Talks With Trump
U.S. stocks shot up Tuesday morning after multiple reports have indicated overseas trading partners are now rushing to negotiate with President Donald Trump over his “reciprocal” tariffs.
Read More U.S. Stocks Rise As Global Trade Partners Seek Tariff Talks With TrumpTrump Extends TikTok Deadline Once More: ‘Pushing For A Bidding War With China’
President Donald Trump has extended the deadline for the popular social media app TikTok, for the next 75 days — pushing for a bidding war with China.
Read More Trump Extends TikTok Deadline Once More: ‘Pushing For A Bidding War With China’OpenAI’s weekly active users surpass 400 million
OpenAI’s weekly active users surged past 400 million in February, highlighting rapid growth in the adoption of artificial intelligence tools.
Read More OpenAI’s weekly active users surpass 400 millionWhat is DeepSeek and why is it disrupting the AI sector?
Chinese startup DeepSeek’s launch of its latest AI models is threatening to upset the technology world order.
Read More What is DeepSeek and why is it disrupting the AI sector?TikTok app unavailable on Apple, Google stores in US despite Trump delaying ban
TikTok remained unavailable on Apple and Google app stores in the U.S., a day after President Donald Trump signed an executive order delaying the ban by 75 days.
Read More TikTok app unavailable on Apple, Google stores in US despite Trump delaying ban